| Literature DB >> 28346393 |
Chang-Wei Li1, Bing Han2, Bing Cai3, Cheng-Bin Cui4.
Abstract
Bioactivity-directed fractionation of antitumor compounds from the stem barks of Choerospondias axillaries (Roxb.) Burtt et Hill (Anacardiaceae) afforded two new cytotoxic bridged-ring ketones, choerosponins A (1) and B (2), and their structures were elucidated by spectroscopic methods; their stereochemistry was determined by NOE difference experiments, CD spectra and the modified Mosher's method. Compound 1 has a rare dioxatricyclo skeleton. Flow cytometry and SRB methods were employed to evaluate the antitumor activity of the two compounds against tsFT210, HCT-15, HeLa, A2780 and MCF-7 cell lines, and both of them showed strong cytotoxicity. MTT and paper disc methods were also used to evaluate their anti-hypoxia and antibacterial activities, and both of them showed no apparent activities.Entities:
Keywords: Choerospondias axillaries; absolute configuration; bridged ring ketones; cytotoxicity
Mesh:
Substances:
Year: 2017 PMID: 28346393 PMCID: PMC6154574 DOI: 10.3390/molecules22040531
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of compounds 1 and 2.
The 600 MHz 1H-NMR and 150 MHz 13C-NMR data a for 1 and 2.
| No. | 1 | 2 | |||||
|---|---|---|---|---|---|---|---|
| δH ( | δc | HMBC(H→C) | δH ( | δc | HMBC(H→C) | ||
| 1 | 212.1 s | 206.0 s | |||||
| 2 | H | 2.57 dd (18.4, 1.4) | 39.5 t | 1, 3, 4 | 2.47 dd (15.8, 2.1) | 48.1 t | 1, 3, 4 |
| 3 | 4.57 m | 71.3 d | 1, 5, 8 | 4.43 m | 72.6 d | 1, 2, 4, 5, 8 | |
| 4 | 4.79 m | 73.4 d | 6, 8 | 4.03 br s | 75.2 d | 2, 3, 5, 6,7 | |
| 5 | H | 2.22 dd (13.8, 1.8) | 35.7 t | 1, 3, 4, 6, 7 | 70.5 s | ||
| 6 | 74.2 s | 2.52 dd (15.5, 1.4) | 55.5 t | 1, 4, 5, 7 | |||
| 7 | H | 1.94 d (13.3) | 46.0 t | 1, 5, 6, 8, 9 | 1.73 dd (14.2, 11.1) | 43.7 t | |
| 8 | 107.6 s | 4.25 m | 69.4 d | 4, 5, 6, 8, 9 | |||
| 9 | H | 1.72 (2H) m | 36.1 t | 7, 8, 10, 11 | 1.38 m | 36.8 t | 3, 9, 10 |
| 10 | 1.42 (2H) m | 23.1 t | 8, 9, 11, 12 | 1.29-1.35 b m | 25.4 t | 7, 8, 10, 11 | |
| 11 | 1.24–1.29 b m | 29.2 t | 9, 10, 12, 13 | 1.22–1.29 b m | 29.5–29.7 b t | 9, 10, 12, 13 | |
| 12 | 1.24–1.29 b m | 29.3 t | 10, 11, 13, 14 | 1.22–1.29 b m | 29.5–29.7 b t | 10, 11, 13, 14 | |
| 13–16 | 1.24–1.29 b m | 29.3-29.5 b t | 11,12,14–16,17,18 | 1.22–1.29 b m | 29.5–29.7 b t | 11, 12~17,18, | |
| 17 | 1.24–1.29 b m | 29.3-29.5 b t | 15, 16, 18, 19 | 1.22–1.29 b m | 29.6 t | 15, 16, 18, 19 | |
| 18 | 1.29–1.35 b m | 29.6 t | 16, 17, 19, 20 | 1.29–1.35 b m | 29.3 t | 16, 17, 19, 20 | |
| 19 | 2.02 (2H) m | 26.9 c t | 17, 18, 20, 21 | 2.02 (2H) m | 26.9 c t | 17, 18, 20, 21 | |
| 20 | 5.35 m | 129.9 d d | 18, 19, 22 | 5.35 m | 129.9 d d | 19, 22 | |
| 21 | 5.35 m | 129.8 d d | 19, 22 | 5.35 m | 129.8 d d | 19, 22 | |
| 22 | 2.02 (2H) m | 27.2 c t | 20, 21, 23, 24 | 2.02 (2H) m | 27.2 c t | 20, 21, 23, 24 | |
| 23 | 1.29–1.35 b m | 22.3 t | 21, 22, 24, 25 | 1.29–1.35 b m | 22.3 t | 21, 22, 24 | |
| 24 | 1.29–1.35 b m | 31.9 t | 22, 23, 25 | 1.29–1.35 b m | 31.9 t | 22, 23 | |
| 25 | 0.90 (3H) t (7.1) | 14.0 q | 23, 24 | 0.90 (3H) t (7.1) | 14.0 q | 23, 24 | |
| 4-O | 2.84 br s | 3 | |||||
| 5-O | 2.36 br s | ||||||
| 6-O | 3.77 s | 1, 5, 6 | |||||
a Data of 1 and 2 in CDCl3 solution. Signal assignments were based on the results of DEPT, 1H-1H COSY, HMQC, HMBC and difference NOE experiments. b The signals could not be assigned exactly because of the signal overlapping. c and d Signal assignments may be interchanged between two signals with the same superscript.
Figure 2(a) 1H-1H COSY and HMBC correlations of 1; (b) Key NOE correlation of 1; (c) The octant projection of 1.
Figure 3(a) The key NOE correlations of 2; (b) The hypothetical octant projection of 2; (c) Values of Δδ (δS-MTPA - δR-MTPA) of the MTPA esters of 2; (d) The practical octant projection of 2.
The inhibiting effect of 1 on HCT-15 and HeLa cells.
| Cells | IR% | IC50 (µM) | ||||
|---|---|---|---|---|---|---|
| 200 µM | 100 µM | 10 µM | 1 µM | 0.1 µM | ||
| HCT-15 | 73.3% | 47.3% | 28.2% | 38.1% | 38.0% | 104.3 |
| HeLa | 62.1% | 40.4% | 35.1% | 34.1% | 32.3% | 144.0 |
The inhibiting effect of 2 on HCT-15, HeLa, A2780 and MCF-7 cells.
| Cells | IR% | IC50 (µM) | ||||
|---|---|---|---|---|---|---|
| 200 µM | 100 µM | 10 µM | 1 µM | 0.1 µM | ||
| HCT-15 | 90.9% | 86.5% | 68.7% | 22.3% | NA | 3.3 |
| HeLa | 64.6% | 86.5% | 42.5% | 24.6% | 26.4% | 11.1 |
| A2780 | 70.9% | 73.1% | 15.5% | NA | NA | 13.2 |
| MCF-7 | 68.3% | 68.0% | 10.2% | 8.1% | NA | 71.1 |
NA: No activity.
Anti-hypoxia effects of 1 and 2 on anoxic tested cells (50 µg/mL).
| Samples | Tested Cells | Cell Viabilities (Mean Value ± SD%, | |
|---|---|---|---|
| Control Group | Test Group | ||
| ECV304 | 22.6 ± 0.1 | 14.0 ± 0.7 | |
| ECV304 | 22.6 ± 0.1 | 1.0 ± 0.5 | |
| Baicalin * | ECV304 | 22.6 ± 0.1 | 51.7 ± 1.7 |
Baicalin * was used as positive control.
Figure 4The plausible biosynthetic pathway of compounds 1 and 2.